Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2016 3
2017 1
2018 5
2019 4
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

16 results
Results by year
Filters applied: . Clear all
Page 1
Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease: A Randomized Clinical Trial.
Howard R, Zubko O, Bradley R, Harper E, Pank L, O'Brien J, Fox C, Tabet N, Livingston G, Bentham P, McShane R, Burns A, Ritchie C, Reeves S, Lovestone S, Ballard C, Noble W, Nilforooshan R, Wilcock G, Gray R; Minocycline in Alzheimer Disease Efficacy (MADE) Trialist Group. Howard R, et al. Among authors: harper e. JAMA Neurol. 2019 Nov 18;77(2):164-74. doi: 10.1001/jamaneurol.2019.3762. Online ahead of print. JAMA Neurol. 2019. PMID: 31738372 Free PMC article.
The role of OPG/RANKL in the pathogenesis of diabetic cardiovascular disease.
Forde H, Davenport C, Harper E, Cummins P, Smith D. Forde H, et al. Among authors: harper e. Cardiovasc Endocrinol Metab. 2018 May 16;7(2):28-33. doi: 10.1097/XCE.0000000000000144. eCollection 2018 Jun. Cardiovasc Endocrinol Metab. 2018. PMID: 31646276 Free PMC article. Review.
Amisulpride for very late-onset schizophrenia-like psychosis: the ATLAS three-arm RCT.
Howard R, Cort E, Bradley R, Harper E, Kelly L, Bentham P, Ritchie C, Reeves S, Fawzi W, Livingston G, Sommerlad A, Oomman S, Nazir E, Nilforooshan R, Barber R, Fox C, Macharouthu A, Ramachandra P, Pattan V, Sykes J, Curran V, Katona C, Dening T, Knapp M, Romeo R, Gray R. Howard R, et al. Among authors: harper e. Health Technol Assess. 2018 Nov;22(67):1-62. doi: 10.3310/hta22670. Health Technol Assess. 2018. PMID: 30507375 Free PMC article. Clinical Trial.
Antipsychotic treatment of very late-onset schizophrenia-like psychosis (ATLAS): a randomised, controlled, double-blind trial.
Howard R, Cort E, Bradley R, Harper E, Kelly L, Bentham P, Ritchie C, Reeves S, Fawzi W, Livingston G, Sommerlad A, Oomman S, Nazir E, Nilforooshan R, Barber R, Fox C, Macharouthu AV, Ramachandra P, Pattan V, Sykes J, Curran V, Katona C, Dening T, Knapp M, Gray R; ATLAS Trialists Group. Howard R, et al. Among authors: harper e. Lancet Psychiatry. 2018 Jul;5(7):553-563. doi: 10.1016/S2215-0366(18)30141-X. Epub 2018 Jun 4. Lancet Psychiatry. 2018. PMID: 29880238 Free PMC article. Clinical Trial.
Vascular calcification in type-2 diabetes and cardiovascular disease: Integrative roles for OPG, RANKL and TRAIL.
Harper E, Forde H, Davenport C, Rochfort KD, Smith D, Cummins PM. Harper E, et al. Vascul Pharmacol. 2016 Jul;82:30-40. doi: 10.1016/j.vph.2016.02.003. Epub 2016 Feb 24. Vascul Pharmacol. 2016. PMID: 26924459 Review.
Improvements in single-use bioreactor film material composition leads to robust and reliable Chinese hamster ovary cell performance.
Kelly PS, Dorival-García N, Paré S, Carillo S, Ta C, Alarcon Miguez A, Coleman O, Harper E, Shannon M, Henry M, Connolly L, Clynes M, Meleady P, Bones J, Barron N. Kelly PS, et al. Among authors: harper e. Biotechnol Prog. 2019 Jul;35(4):e2824. doi: 10.1002/btpr.2824. Epub 2019 May 6. Biotechnol Prog. 2019. PMID: 31017345
Assessment of need and practice for assistive technology and telecare for people with dementia-The ATTILA (Assistive Technology and Telecare to maintain Independent Living At home for people with dementia) trial.
Forsyth K, Henderson C, Davis L, Singh Roy A, Dunk B, Curnow E, Gathercole R, Lam N, Harper E, Leroi I, Woolham J, Fox C, O'Brien J, Bateman A, Poland F, Bentham P, Burns A, Davies A, Gray R, Bradley R, Knapp M, Newman S, McShane R, Ritchie C, Talbot E, Hooper E, Winson R, Scutt B, Ordonez V, Nunn S, Lavelle G, Howard R. Forsyth K, et al. Among authors: harper e. Alzheimers Dement (N Y). 2019 Sep 3;5:420-430. doi: 10.1016/j.trci.2019.07.010. eCollection 2019. Alzheimers Dement (N Y). 2019. PMID: 31517029 Free PMC article.
RANKL Inhibits the Production of Osteoprotegerin from Smooth Muscle Cells under Basal Conditions and following Exposure to Cyclic Strain.
Davenport C, Harper E, Rochfort KD, Forde H, Smith D, Cummins PM. Davenport C, et al. Among authors: harper e. J Vasc Res. 2018;55(2):111-123. doi: 10.1159/000486787. Epub 2018 Apr 10. J Vasc Res. 2018. PMID: 29635231 Free PMC article.
The beneficial pleiotropic effects of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) within the vasculature: A review of the evidence.
Forde H, Harper E, Davenport C, Rochfort KD, Wallace R, Murphy RP, Smith D, Cummins PM. Forde H, et al. Among authors: harper e. Atherosclerosis. 2016 Apr;247:87-96. doi: 10.1016/j.atherosclerosis.2016.02.002. Epub 2016 Feb 9. Atherosclerosis. 2016. PMID: 26878368 Review.
Activation of the non-canonical NF-κB/p52 pathway in vascular endothelial cells by RANKL elicits pro-calcific signalling in co-cultured smooth muscle cells.
Harper E, Rochfort KD, Forde H, Davenport C, Smith D, Cummins PM. Harper E, et al. Cell Signal. 2018 Jul;47:142-150. doi: 10.1016/j.cellsig.2018.04.004. Epub 2018 Apr 17. Cell Signal. 2018. PMID: 29678621 Free PMC article.
16 results
Jump to page
Feedback